Comparison of Effect on Sicca Symptoms of Anticentromere Antibody–positive Sjögren Syndrome and Primary Sjögren Syndrome Alone

REFERENCES

1. 1.↵
   1. Hollander JL

   . Arthritis and allied conditions: a textbook of rheumatology. Philadelphia: Lea and Febiger; 1960:988.
2. 2.↵
   1. Avouac J,
   2. Sordet C,
   3. Depinay C,
   4. Ardizonne M,
   5. Vacher-Lavenu MC,
   6. Sibilia J,
   7. et al.

   Systemic sclerosis-associated Sjögren’s syndrome and relationship to the limited cutaneous subtype: results of a prospective study of sicca syndrome in 133 consecutive patients. Arthritis Rheum 2006;54:2243–9.

   OpenUrlCrossRefPubMed
3. 3.↵
   1. Vitali C,
   2. Bombardieri S,
   3. Jonsson R,
   4. Moutsopoulos HM,
   5. Alexander EL,
   6. Carsons SE,
   7. et al;
   8. European Study Group on Classification Criteria for Sjögren’s Syndrome

   . Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554–8.

   OpenUrlAbstract/FREE Full Text
4. 4.↵
   1. Shiboski SC,
   2. Shiboski CH,
   3. Criswell L,
   4. Baer A,
   5. Challacombe S,
   6. Lanfranchi H,
   7. et al;
   8. Sjögren’s International Collaborative Clinical Alliance (SICCA) Research Groups

   . American College of Rheumatology classification criteria for Sjögren’s syndrome: a data-driven, expert consensus approach in the Sjögren’s International Collaborative Clinical Alliance cohort. Arthritis Care Res 2012;64:475–87.

   OpenUrlCrossRef
5. 5.↵
   1. Bongi SM,
   2. Melchiorre D

   . Primary Sjögren’s syndrome: diagnostic criteria, diagnostic aspects and controversies. Pain Clin 2002;13:293–304.

   OpenUrl
6. 6.↵
   1. Baldini C,
   2. Giusti L,
   3. Bazzichi L,
   4. Lucacchini A,
   5. Bombardieri S

   . Proteomic analysis of the saliva: a clue for understanding primary from secondary Sjögren’s syndrome? Autoimmun Rev 2008;7:185–91.

   OpenUrlCrossRefPubMed
7. 7.↵
   1. Salliot C,
   2. Mouthon L,
   3. Ardizzone M,
   4. Sibilia J,
   5. Guillevin L,
   6. Gottenberg JE,
   7. et al.

   Sjögren’s syndrome is associated with and not secondary to systemic sclerosis. Rheumatology 2007;46:321–6.

   OpenUrlCrossRefPubMed
8. 8.↵
   1. Baldini C,
   2. Mosca M,
   3. Della Rossa A,
   4. Pepe P,
   5. Notarstefano C,
   6. Ferro F,
   7. et al.

   Overlap of ACA-positive systemic sclerosis and Sjögren’s syndrome: a distinct clinical entity with mild organ involvement but at high risk of lymphoma. Clin Exp Rheumatol 2013;31:272–80.

   OpenUrlPubMed
9. 9.↵
   1. Nakamura H,
   2. Kawakami A,
   3. Hayashi T,
   4. Iwamoto N,
   5. Okada A,
   6. Tamai M,
   7. et al.

   Anti-centromere antibody-seropositive Sjögren’s syndrome differs from conventional subgroup in clinical and pathological study. BMC Musculoskelet Disord 2010;11:140.

   OpenUrlCrossRefPubMed
10. 10.↵
    1. Hayashi N,
    2. Koshiba M,
    3. Nishimura K,
    4. Sugiyama D,
    5. Nakamura T,
    6. Morinobu S,
    7. et al.

    Prevalence of disease-specific antinuclear antibodies in general population: estimates from annual physical examinations of residents of a small town over a 5-year period. Mod Rheumatol 2008;18:153–60.

    OpenUrlCrossRefPubMed
11. 11.↵
    1. Kassan SS,
    2. Moutsopoulos HM

    . Clinical manifestations and early diagnosis of Sjögren syndrome. Arch Gen Intern Med 2004;164:1275–84.

    OpenUrl
12. 12.↵
    1. Prause JU,
    2. Kriegbaum NJ,
    3. Manthorpe R,
    4. Oxholm P

    . Rose bengal score—a possible key parameter when evaluating disease level and progression in primary Sjögren’s syndrome. J Autoimmun 1989;2:501–7.

    OpenUrlPubMed
13. 13.↵
    1. Knezovic I,
    2. Alajbeg I,
    3. Karlovic D,
    4. Pavan J,
    5. Vrkic N,
    6. Biscan A

    . Differential diagnostic performance of Rose Bengal Score Test in Sjögren’s syndrome patients. Coll Antropol 2011;35:1105–13.

    OpenUrlPubMed
14. 14.↵
    1. Speight PM,
    2. Kaul A,
    3. Melsom RD

    . Measurement of whole unstimulated salivary flow in the diagnosis of Sjögren’s syndrome. Ann Rheum Dis 1992;51:499–502.

    OpenUrlAbstract/FREE Full Text
15. 15.↵
    1. Miyawaki S,
    2. Asanuma H,
    3. Nishiyama S,
    4. Yoshinaga Y

    . Clinical and serological heterogeneity in patients with anticentromere antibodies. J Rheumatol 2005;32:1488–94.

    OpenUrlAbstract/FREE Full Text
16. 16.↵
    1. Osial TA Jr,
    2. Whiteside TL,
    3. Buckingham RB,
    4. Singh G,
    5. Barnes EL,
    6. Pierce JM,
    7. et al.

    Clinical and serologic study of Sjögren’s syndrome in patients with progressive systemic sclerosis. Arthritis Rheum 1983;26:500–8.

    OpenUrlPubMed
17. 17.↵
    1. Bell S,
    2. Krieg T,
    3. Meurer M

    . Antibodies to Ro/SSA detected by ELISA: correlation with clinical features in systemic scleroderma. Br J Dermatol 1989;121:35–41.

    OpenUrlPubMed
18. 18.↵
    1. Drosos AA,
    2. Andonopoulos AP,
    3. Costopoulos JS,
    4. Stavropoulos ED,
    5. Papadimitriou CS,
    6. Moutsopoulos HM

    . Sjögren’s syndrome in progressive systemic sclerosis. J Rheumatol 1988;15:965–8.

    OpenUrlPubMed
19. 19.↵
    1. Katano K,
    2. Kawano M,
    3. Koni I,
    4. Sugai S,
    5. Muro Y

    . Clinical and laboratory features of anticentromere antibody positive primary Sjögren’s syndrome. J Rheumatol 2001;28:2238–44.

    OpenUrlAbstract/FREE Full Text
20. 20.↵
    1. Hida A,
    2. Kawabe Y,
    3. Kawakami A,
    4. Migita K,
    5. Tominaga M,
    6. Nakamura H,
    7. et al.

    HTLV-I associated Sjögren’s syndrome is aetiologically distinct from anti-centromere antibodies positive Sjögren’s syndrome. Ann Rheum Dis 1999;58:320–2.

    OpenUrlAbstract/FREE Full Text
21. 21.↵
    1. Jimenez SA,
    2. Derk CT

    . Following the molecular pathways toward an understanding of the pathogenesis of systemic sclerosis. Ann Gen Intern Med 2004;140:37–50.

    OpenUrl